Table 2

Pre-/Post IV Treatment Data – 39 Patients Percent Predicted, Pre- and Post- infusion with % improvement



FVC (L)
 FEV 1 (L)
 PEF (L/S)
 FEF 25–75 (L/S)
 FEF 75–85 (L/S)

Sex
 Age
 % Predicted
 % Predicted
 % Predicted
 % Predicted
 % Predicted
Patient

Pre
 Post
 %
 Pre
 Post
 %
 Pre
 Post
 %
 Pre
 Post
 %
 Pre
 Post
 %
A, L.
 M
 55
 36
 72
 100%
 36
 79
 119%
 64
 92
 44%
 35
 129
 269%
 32
 112
 250%
A, S.
 F
 48
 28
 50
 79%
 30
 48
 60%
 40
 78
 95%
 30
 40
 33%
 40
 38
 -5%
B, M.
 F
 57
 69
 100
 45%
 48
 81
 69%
 45
 115
 156%
 24
 39
 63%
 30
 32
 7%
B, R.
 M
 46
 73
 93
 27%
 69
 87
 26%
 95
 106
 12%
 57
 70
 23%
 66
 67
 2%
B, V.
 F
 39
 34
 67
 97%
 34
 72
 112%
 51
 59
 16%
 38
 96
 153%
 26
 98
 277%
B, V.
 F
 70
 38
 54
 42%
 32
 47
 47%
 32
 53
 66%
 18
 30
 67%
 25
 34
 36%
C, D.
 M
 59
 27
 30
 11%
 14
 17
 21%
 10
 12
 20%
 10
 10
 0%
 32
 28
 -13%
C, A.
 F
 33
 90
 91
 1%
 80
 98
 23%
 115
 142
 23%
 60
 108
 80%
 65
 116
 78%
C, K.
 F
 35
 45
 62
 38%
 34
 52
 53%
 32
 56
 75%
 22
 36
 64%
 32
 41
 28%
D, C.
 F
 33
 65
 65
 0%
 49
 56
 14%
 62
 65
 5%
 31
 41
 32%
 42
 51
 21%
D, B.
 M
 49
 65
 80
 23%
 72
 83
 15%
 68
 88
 29%
 75
 80
 7%
 146
 147
 1%
D, K.
 F
 48
 61
 74
 21%
 56
 70
 25%
 89
 95
 7%
 39
 60
 54%
 29
 33
 14%
F, L.
 M
 58
 26
 29
 12%
 12
 13
 8%
 7
 8
 14%
 7.4
 8.1
 9%
 22
 26
 18%
G, W.
 M
 74
 48
 67
 40%
 25
 57
 128%
 16
 88
 450%
 11
 37
 236%
 38
 63
 66%
G, B.
 M
 45
 83
 113
 36%
 83
 101
 22%
 94
 149
 59%
 81
 70
 -14%
 89
 60
 -33%
G, G.
 F
 42
 83
 93
 12%
 46
 82
 78%
 24
 59
 146%
 31
 66
 113%
 55
 79
 44%
G, L.
 F
 63
 50
 78
 56%
 36
 60
 67%
 52
 71
 37%
 17
 29
 71%
 21
 29
 38%
J, E.
 F
 63
 47
 85
 81%
 38
 84
 121%
 43
 64
 49%
 19
 79
 316%
 20
 55
 175%
K, H.
 F
 49
 58
 72
 24%
 59
 72
 22%
 82
 99
 21%
 53
 62
 17%
 76
 86
 13%
M, A.
 F
 46
 85
 97
 14%
 79
 89
 13%
 61
 86
 41%
 71
 71
 0%
 73
 68
 -7%
M, W.
 M
 85
 74
 77
 4%
 69
 90
 30%
 46
 82
 78%
 50
 119
 138%
 148
 458
 209%
M, C.
 F
 36
 93
 85
 -9%
 52
 53
 2%
 30
 46
 53%
 26
 25
 -4%
 26
 25.5
 -2%
M, J.
 M
 64
 74
 75
 1%
 49
 57
 16%
 47
 60
 28%
 25
 37
 48%
 57
 83
 46%
O, M
 F
 49
 90
 99
 10%
 98
 114
 16%
 88
 167
 90%
 114
 168
 47%
 145
 214
 48%
P, O.
 F
 47
 54
 72
 33%
 52
 76
 46%
 85
 84
 -1%
 46
 82
 78%
 40
 74
 85%
R, B.
 F
 69
 21
 23
 10%
 16
 19
 19%
 13
 17
 31%
 10
 11
 10%
 21
 22
 5%
S, M.
 F
 60
 56
 94
 68%
 45
 88
 96%
 60
 104
 73%
 26
 66
 154%
 26
 51
 96%
S, J.
 M
 54
 98
 166
 69%
 76
 96
 26%
 77
 70
 -9%
 34
 39
 15%
 70
 90
 29%
S, S.
 M
 40
 73
 85
 16%
 58
 69
 19%
 68
 85
 25%
 36
 40
 11%
 43
 38
 -12%
S, D.
 F
 64
 40
 56
 40%
 25
 33
 32%
 18
 21
 17%
 15
 14
 -7%
 42
 34
 -19%
S, W.
 M
 44
 71
 80
 13%
 52
 65
 25%
 42
 60
 43%
 31
 40
 29%
 31
 38
 23%
T, P.
 F
 45
 41
 59
 44%
 26
 46
 77%
 22
 73
 232%
 17
 27
 59%
 26
 32
 23%
W, P.
 F
 65
 48
 76
 58%
 17
 31
 82%
 9
 21
 133%
 9
 11
 22%
 20
 19
 -3%
W, B.
 M
 38
 54
 72
 33%
 42
 58
 38%
 32
 46
 44%
 25
 37
 48%
 37
 50
 35%
W, R.
 M
 40
 77
 77
 0%
 34
 41
 21%
 27
 33
 22%
 12
 16
 33%
 21
 24
 14%
W, C.
 F
 55
 28
 39
 39%
 20
 28
 40%
 17
 26
 53%
 12
 16
 33%
 20
 23
 15%
W, G.
 F
 70
 101
 108
 7%
 78
 98
 26%
 34
 82
 141%
 51
 65
 27%
 49
 62
 27%
Z, A.
 F
 43
 62
 75
 21%
 64
 75
 17%
 107
 87
 -19%
 68
 88
 29%
 57
 49
 -14%
Average:
52
 60
 76
 28%
 48
 65
 38%
 50
 72
 44%
 35
 54
 54%
 48
 70
 44%
Average Overall Improvement
 45%











Results were measured as percentage improvement of the percentage predicted on the Knudsen scale

Shrader Nutrition Journal 2004 3:6   doi:10.1186/1475-2891-3-6

Open Data